ClinicalTrials.govpublic full text
Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer
non small cell lung cancer, stage iii non-small-cell lung cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 300248
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.